TSS
GILD icon

Two Sigma Securities’s Gilead Sciences GILD Stock Holding History

Two Sigma Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,400
Closed -$3.55M – 2259
2024
Q3 		$3.55M Sell
42,400
-1,000
-2% -$76.3K 0.06% 365
2024
Q2 		$2.98M Buy
43,400
+6,800
+19% +$454K 0.04% 538
2024
Q1 		$2.68M Sell
36,600
-55,700
-60% -$4.28M 0.03% 633
2023
Q4 		$7.48M Buy
92,300
+29,000
+46% +$2.26M 0.07% 266
2023
Q3 		$4.74M Sell
63,300
-10,000
-14% -$769K 0.05% 382
2023
Q2 		$5.65M Buy
73,300
+36,100
+97% +$2.88M 0.08% 256
2023
Q1 		$3.09M Buy
37,200
+20,300
+120% +$1.68M 0.06% 387
2022
Q4 		$1.45M Sell
16,900
-54,300
-76% -$4.3M 0.04% 518
2022
Q3 		$4.39M Sell
71,200
-150,700
-68% -$9.5M 0.13% 174
2022
Q2 		$13.7M Buy
221,900
+131,300
+145% +$8.13M 0.49% 33
2022
Q1 		$5.39M Buy
90,600
+80,600
+806% +$5.15M 0.19% 119
2021
Q4 		$726K Sell
10,000
-46,900
-82% -$3.23M 0.03% 372
2021
Q3 		$3.97M Buy
56,900
+21,100
+59% +$1.48M 0.12% 153
2021
Q2 		$2.46M Buy
35,800
+25,300
+241% +$1.69M 0.07% 198
2021
Q1 		$679K Sell
10,500
-56,500
-84% -$3.64M 0.04% 225
2020
Q4 		$3.9M Buy
67,000
+51,900
+344% +$3.13M 0.09% 135
2020
Q3 		$954K Sell
15,100
-2,400
-14% -$166K 0.02% 367
2020
Q2 		$1.35M Sell
17,500
-15,100
-46% -$1.16M 0.03% 317
2020
Q1 		$2.44M Sell
32,600
-302,100
-90% -$20.9M 0.05% 219
2019
Q4 		$21.7M Buy
334,700
+221,800
+196% +$14.4M 0.15% 88
2019
Q3 		$7.16M Buy
112,900
+12,100
+12% +$791K 0.07% 232
2019
Q2 		$6.81M Buy
100,800
+62,000
+160% +$4.08M 0.07% 176
2019
Q1 		$2.52M Sell
38,800
-65,400
-63% -$4.35M 0.02% 273
2018
Q4 		$6.52M Sell
104,200
-53,300
-34% -$3.73M 0.08% 132
2018
Q3 		$12.2M Sell
157,500
-103,300
-40% -$7.8M 0.08% 172
2018
Q2 		$18.5M Sell
260,800
-80,900
-24% -$5.71M 0.09% 164
2018
Q1 		$25.8M Buy
341,700
+299,200
+704% +$23.8M 0.14% 121
2017
Q4 		$3.04M Buy
+42,500
New +$3.23M 0.08% 184

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Two Sigma Securities's GILD Position: Q4 2025 in Review

Two Sigma Securities sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,085 shares — an estimated $342K sold.

Two Sigma Securities first reported a position in GILD in Q2 2015 and held it in 25 quarters. The position peaked at $3.92M in Q1 2018. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Two Sigma Securities reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 3,085 Gilead Sciences shares in Q4 2025, an estimated $342K.
  • Two Sigma Securities first reported a position in Gilead Sciences in Q2 2015 and held it in 25 quarters.
  • Two Sigma Securities's Gilead Sciences position peaked at $3.92M in Q1 2018.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.